Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

January 23, 2024

Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy

Learn More
January 11, 2024

The burden of inflammatory bowel disease (IBD) in the US

Learn More
October 16, 2023

Phages and Synthetic Biology Team Up to Tackle Antimicrobial Resistance

Learn More
October 13, 2023

Dangerous ‘Superbugs’ Are on the Rise. What Can Stop Them?

Learn More
July 11, 2023

The burden of complicated urinary tract infections (cUTIs) in the US

Learn More
June 30, 2023

Going Viral. Phage therapy has been touted as the replacement to antibiotics. But what if that comparison is holding it back?

Learn More
February 18, 2023

LOCUS BIOSCIENCES: DELIVERING PRECISION MEDICINE ONE BACTERIOPHAGE AT A TIME.

Learn More
February 14, 2023

Leaders in Life Sciences Podcast: (Ep 5) Focus on Team First with Paul Garofolo

Learn More
November 10, 2022

2022 Fast 50 Awards: No. 11 – Locus Biosciences

Learn More
September 13, 2022

Locus Biosciences Announces First Patient Treated in the ELIMINATE Registrational Phase 2/3 Trial of LBP-EC01 for Urinary Tract Infections

Learn More